Business
Mauna Kea Technologies Announces Initiation of Coverage by Allinvest Securities
PARIS & BOSTON, January 26, 2026--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) announces today the initiation of coverage of its stock by the financial research firm Allinvest Securities.
About this update from Euroland Corporate Sa
[{"type":"text","content":"PARIS & BOSTON, January 26, 2026--(BUSINESS WIRE)--Regulatory News:","length":71,"tagName":"p"},{"type":"text","content":"Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) announces today the initiation of coverage of its stock by the financial research firm Allinvest Securities.","length":265,"tagName":"p"},{"type":"text","content":"In a study entitled "Après la sauvegarde, le réveil de la croissance" (After the safeguard proceedings, the rebirth of growth), Allinvest Securities issues a BUY recommendation with a target price of €0.20 per share, representing a potential upside of +54% compared to the closing share price on January 23, 2026 (€0.13).","length":331,"tagName":"p"},{"type":"text","content":"As a reminder, the stock is already covered by Euroland Corporate with a price target of €0.50.","length":95,"tagName":"p"},{"type":"text","content":"About Mauna Kea Technologies","length":28,"tagName":"p"},{"type":"text","content":"Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio® platform is used globally across a wide range of medical specialties and is making a transformative change in the way physicians diagnose and treat patients. For more information, visit www.maunakeatech.com.","length":643,"tagName":"p"},{"type":"text","content":"Disclaimer","length":10,"tagName":"p"},{"type":"text","content":"This press release contains forward-looking statements about Mauna Kea Technologies and its business. All statements other than statements of historical fact included in this press release, including, but not limited to, statements regarding Mauna Kea Technologies' financial condition, business, strategies, plans and objectives for future operations are forward-looking statements. Mauna Kea Technologies believes that these forward-looking statements are based on reasonable assumptions. However, no assurance can be given that the ...